P Muglia

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts
    P Muglia
    Genetics Division, Drug Discovery, GlaxoSmithKline R and D, Verona, Italy
    Mol Psychiatry 15:589-601. 2010
  2. ncbi Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13
    C Francks
    Division of Medical Genetics, GlaxoSmithKline, Verona, Italy
    Mol Psychiatry 15:319-25. 2010
  3. ncbi Family history of depression is associated with younger age of onset in patients with recurrent depression
    F Tozzi
    Medical Genetics, Clinical Pharmacology and Discovery Medicine, GlaxoSmithKline R and D, Verona, Italy
    Psychol Med 38:641-9. 2008

Detail Information

Publications3

  1. ncbi Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts
    P Muglia
    Genetics Division, Drug Discovery, GlaxoSmithKline R and D, Verona, Italy
    Mol Psychiatry 15:589-601. 2010
    ..Meta-analysis of larger datasets is warranted to identify SNPs with smaller effects or with rarer allele frequencies that contribute to the risk of MDD...
  2. ncbi Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13
    C Francks
    Division of Medical Genetics, GlaxoSmithKline, Verona, Italy
    Mol Psychiatry 15:319-25. 2010
    ....
  3. ncbi Family history of depression is associated with younger age of onset in patients with recurrent depression
    F Tozzi
    Medical Genetics, Clinical Pharmacology and Discovery Medicine, GlaxoSmithKline R and D, Verona, Italy
    Psychol Med 38:641-9. 2008
    ..The present study tested whether the presence of FH for depression or anxiety in first-degree relatives determines younger age of onset for depression...